ScholarIQanswers from OpenAlex & ORCID
Yukito Ichinose
ResearcherPublications, citations & collaboration network
Yukito Ichinose is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yukito Ichinose have?
ScholarIQindexed works
Yukito Ichinose has 329 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yukito Ichinose have?
ScholarIQcitation count
Yukito Ichinose has 18,274 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yukito Ichinose?
ScholarIQh-index
Yukito Ichinose has an h-index of 49 in OpenAlex.
What is the i10-index of Yukito Ichinose?
ScholarIQi10-index
Yukito Ichinose has an i10-index of 151 in OpenAlex.
What is the OpenAlex record for Yukito Ichinose?
ScholarIQopenalex
The OpenAlex for Yukito Ichinose is on the source record.
What are the most-cited papers on Yukito Ichinose?
ScholarIQmost cited works
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony Mok, Yi‐Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose, Yutaka Nishiwaki, Yuichiro Ohe, Jin-Ji Yang, Busyamas Chewaskulyong, Haiyi Jiang, Emma Duffield, Claire Watkins, Alison Armour, Masahiro Fukuoka
Interstitial Lung Disease in Japanese Patients with Lung Cancer
Shoji Kudoh, Harubumi Kato, Yutaka Nishiwaki, Masahiro Fukuoka, Kouichiro Nakata, Yukito Ichinose, Masahiro Tsuboi, Soichiro Yokota, Kazuhiko Nakagawa, Moritaka Suga, Haiyi Jiang, Y. Itoh, Alison Armour, Claire Watkins, Tim Higenbottam, Fredrik Nyberg
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura, Nobuyuki Yamamoto, Masahiro Tsuboi, Kazuhiko Nakagawa, Tetsu Shinkai, Shunichi Negoro, Fumio Imamura, Kenji Eguchi, Koji Takeda, Akira Inoue, Keisuke Tomii, Masao Harada, Noriyuki Masuda, Haiyi Jiang, Y. Itoh, Yukito Ichinose, Nagahiro Saijo, Masahiro Fukuoka
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
Seiji Niho, Hideo Kunitoh, Hiroshi Nokihara, Takeshi Horai, Yukito Ichinose, Toyoaki Hida, Nobuyuki Yamamoto, Masaaki Kawahara, Tetsu Shinkai, Kazuhiko Nakagawa, Kaoru Matsui, Shunichi Negoro, Akira Yokoyama, Shinzoh Kudoh, Katsuyuki Kiura, Kiyoshi Mori, Hiroaki Okamoto, Hiroshi Sakai, Koji Takeda, Soichiro Yokota, Nagahiro Saijo, Masahiro Fukuoka
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: An analysis in each pathologic stage
Yukito Ichinose, Tokujiro Yano, Hiroshi Asoh, Hideki Yokoyama, Ichiro Yoshino, Yasaburo Katsuda